- Market Realist•48 minutes ago
In the US, Pfizer (PFE)’s Lyrica is protected by its composition of matter patent until December 30, 2018. However, the drug lost regulatory exclusivity in major European markets in July 2014.
- Market Realist•3 hours ago
Based on the recommendations of 27 brokerage firms in a Bloomberg survey, 57.7% of analysts gave Pfizer (PFE) a “buy” recommendation while 42.3% analysts rated the company a “hold.” None of the analysts ...
- Financial Times•11 hours ago
Leaders often define themselves by bold acts: a takeover, a corporate rescue. Success, though, is determined by a trait less obvious to outsiders their ability to handle pressure. Dennis Kozlowski told ...
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
As of 10:53 AM EDT. Market open.
|Bid||32.20 x 1900|
|Ask||32.21 x 14300|
|Day's Range||32.20 - 32.36|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.61|
|Avg Vol (3m)||18,959,096|
|Dividend & Yield||1.20 (3.73%)|